The Helmholtz Association is pooling its commitment to prevention research with the launch of the Helmholtz Health Prevention Task Force. In a strategy paper published in “Nature Medicine,“ the committee outlines initial concepts for integrating…
REMATIQ, the first AI-native platform for automated product compliance in MedTech, has raised €5.4 million in a seed funding round. The round is led by Project A Ventures, with participation from Amino Collective and HelloWorld, and complemented by…
• 20,500 visitors, 900 exhibitors from almost 30 countries and 470 speakers in 200 sessions
• PAICON wins DMEA nova Award for the most convincing digital health idea
• DMEA 2026 from April 21 to 23, 2026
Max Delbrück Center and Helmholtz Imaging scientists have developed open-source software that simplifies the study of cell polarity with fluorescence microscopy. Published in “Nature Communications,” the innovation may streamline research on many…
Effect of mechanical stress on cartilage degradation studied in vitro
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) and Actinium Pharmaceuticals, Inc. announced that they have entered into an agreement for the supply of Actinium-225 (Ac-225). With this agreement, Actinium Pharmaceuticals will have access to Eckert &…
The loss of muscle mass and strength poses an increasingly significant challenge for an ageing society. Prof. Kristina Norman's team at the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) has now shown that amino acid profiles could…
AMBOSS, the leading resource for medical education and clinical decision-making in Germany and the US, closes a €240M financing round with new long-term investors, supporting the exploration of additional international markets and the expansion of…
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) and AtomVie Global Radiopharma Inc. (AtomVie) today announced a global supply agreement. Eckert & Ziegler will provide its high-quality non-carrier added Lutetium-177 chloride (n.c.a. Lu-177,…
A study at Charité – Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer sufficient…
